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Abstract: Chemical compounds isolated from natural sources offer unique opportunities to understand life on a 
molecular level. In this account, an overview over different natural products investigated in our research group 
over the last decade is presented. We have shown that protein localization in living cells can be controlled by an-
guinomycins and derivatives. Furthermore, a truncated analog, SB640, was discovered that retained much of the 
natural product potency. Detailed studies of the iron chelator anachelin led to the development of a bio-inspired 
platform for the generation of bioactive interfaces. The discovery of natural products isolated from cyanobacteria 
such as nostocarboline, aerucyclamides, cyanopetolin 1020 and various microcystins is presented and their mo-
lecular mechanisms of action were investigated. The last part describes the synthesis and evaluation of various 
natural products involved in neuritogenesis and synapse reconstruction such as withanolide A, militarinone, fari-
nosone A and C and torrubiellone C. Their potential with regard to their use in regenerative medicine is discussed.
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Introduction
The impact of natural products on society 
continues to be a major driver for many po-
litical, economic and environmental devel-
opments in the 21st century. Trade of recre-
ational drugs from natural sources and their 
misuse appears to grow constantly all over 
the globe, with devastating consequences 
on the political, economic and societal 
stability of many countries. Consumer de-
mand for natural flavors, fragrances and 
dyes is increasing, which can put con-
straints on economies of the producing 
countries with associated environmental 
problems such as deforestation, monocul-
ture and high-dependency of global mar-
ket prices for goods. In medicine, natural 
products remain a prime source for new 
compounds and therapeutic approaches, 
despite a significant decline of industrial 
research activities in this field.[1] One ex-
ample of a newly introduced compound 
opening up new therapeutic avenues based 
on natural products is represented by fin-
golimod (FTY-720, Novartis).[2] Complex 
marine natural products derivatives made 
de novo by organic synthesis continue to 
enter the market, with eribulin/E7389 as 
the most recent example.[3] The long time-
line of development for both these com-
pounds exemplifies challenges associated 
with natural products for the pharmaceuti-
cal industry, but opens up opportunities for 
research regarding lead identification in 
academia. A significant portion of research 
for both aforementioned compounds was 
also contributed by academic research 
groups, which was also the case for other 
famous anticancer natural products.[1–3] 
Exploiting such opportunities constitutes a 
focus in our research group, in the larger 
context of our research program on con-
trolling biological processes by natural 
products and their synthetic derivatives. In 
this account, we will give an overview of 
the different research problems in biology 
that have been successfully addressed by 
natural products in our group.
Controlling Protein Transport in 
Live Cells by Small Molecules
Controlling the localization and trans-
port of macromolecules by small mol-
ecules constitutes an interesting interdis-
ciplinary fundamental problem with large 
significance in biology and also inherent 
chemical challenges.[4] The central chemi-
cal issue remains in the problem of inhib-
iting protein–protein interactions between 
protein transporter and cargo protein by 
small molecules. We have addressed this 
challenge and have identified the small 
molecule SB640, which is able to block 
CRM1-mediated nucleocytoplasmic trans-
port at concentrations as low as 25 nM 
(Fig. 1).[5a] The identification of this com-
pound was only possible by extensive total 
synthesis studies on the anguinomycins C 
and D,[5] which are members of the lepto-
mycin class of polyketides. The approach 
of diverted total synthesis[6] – in this case 
by protodepalladation of a synthetic inter-
mediate – proved successful in the iden-
tification of SB640.[5a] The mechanism of 
action of this compound on inhibiting pro-
tein–protein interactions was studied by 
computational approaches, which revealed 
how SB640 is able to bind to CRM1 and 
shut down its activity.[5a] Based on these 
results, we have hypothesized that vinyl 
or styryl dihydropyrone derivatives con-
stitute a general class of protein transport 
inhibitors displaying a mechanism of ac-
tion similar to SB640. Investigating this 
hypothesis, we have demonstrated that 
the anticancer compound goniothalamin 
is also able to block nuclear export, albeit 
at higher concentrations.[7] This study de-
tailed a clear mechanistic picture of this 
compound and, likely, more natural vinyl 
dihydropyrones interfere with biological 
systems in a similar manner. For other 
natural products interfering with nuclear 
export, the interested reader is referred to 
recent review articles.[4]
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biology of the cyanobacterial iron chela-
tor anachelin (Fig. 2).[8] First, a synthetic 
strategy based on a postulated biogenesis 
was developed,[9a] that led subsequently 
to the total synthesis of this siderophore 
and establishment of its configuration.[9b] 
The hypothetical biogenesis was inves-
tigated by in vitro enzymatic studies[10] 
and the mechanistic role of the quaternary 
ammonium group was addressed.[11] We 
then became interested in the question on 
how this siderophore acquires Fe from the 
environment. It has been postulated that 
siderophores are able to bind to mineral 
surfaces,[12a] which had been supported by 
laboratory experiments for Pseudomonas 
siderophores.[12b] Therefore, we wanted to 
use the catecholate fragment of anachelin 
as an anchor for the bio-inspired modifi-
cation of TiO
2
 surfaces. Interestingly, in 
collaboration with the group of Marcus 
Textor at ETH and the spin-off company 
SurfaceSolutionS, we were able to dem-
onstrate that indeed the anachelin chromo-
phore is strongly binding to surfaces.[13] 
This approach, which improves on ear-
lier polymeric approaches based on mus-
sel adhesive proteins,[14] allowed for the 
generation of both protein resistant sur-
faces, as well as of antimicrobial surfaces 
via the immobilization of vancomycin.[15] 
Chemical tailoring of this anchor enabled 
a detailed understanding of the structural 
requirements for binding[16] and mechanis-
tic studies on the anachelin chromophore 
have highlighted the role of the elec-
tron-withdrawing ammonium group.[11] 
Based on this knowledge, it could also be 
demonstrated that it can be replaced by 
the electronically similar nitrodopamine 
residue.[17] In addition, ultra-stable coat-
ings based on catecholate polymers have 
resisted the attachment of blue-green algae 
for over 100 days.[18] Related approaches 
to this bio-inspired surface modification 
platform have been used successfully for a 
variety of applications by other groups.[19]
Bioactive Natural Products from 
Cyanobacteria
As we have investigated the cyano-
bacterial siderophore anachelin for over 
a decade, we became interested in natural 
products produced by cyanobacteria.[20] 
Two lines of research related to natural 
products as powerful modulators of biolog-
ical processes are currently pursued in this 
field: On one side, we are interested in nat-
ural products that display biological activi-
ty that could be useful in the context of dis-
eases ranging from Alzheimer’s to tropical 
diseases, for example malaria (Fig. 3).[20a,b] 
In this field, we have (in collaboration 
with the group of Professor Jüttner at the 
University of Zurich) structurally charac-
A Bio-Inspired Surface 
Modification Platform Based on the 
Siderophore Anachelin
Natural products that facilitate iron 
uptake for the producer (so-called sidero-
phores) constitute important compounds 
for the biochemistry of many organisms. 
This holds especially true for cyanobac-
teria, as these prokaryotic phototrophs of-
ten grow in aquatic environments, where 
the available Fe concentration in water is 
very low. We have carried out an extensive 
research program on the chemistry and 
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natural products can lead to surprising ap-
plications, such as from an iron chelator 
to surface modification anchors or from 
algicidal compounds to antimalarials. 
Chemical interference of biological sys-
tems with natural products thus emerges 
as a key scientific approach within the 
broader context of chemical biology.
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terized the cyanobacterial alkaloid nosto-
carboline.[21] This compound displayed in-
hibitory activity against other algae, which 
could be relevant with regard to its ecologi-
cal role.[22] As the malaria parasite contains 
also an organelle potentially of algal origin, 
we tested nostocarboline and derivatives 
against Plasmodium falciparum, and good 
in vitro[23] and moderate in vivo[24] efficacy 
was found. This prompted us to search for 
additional antimalarial agents from cyano-
bacteria, in this way the aerucyclamides 
A–D, ribosomally produced peptides from 
Microcystis, were found to be inhibitory to 
P. falciparum.[25]
On the other hand, we are interested in 
characterizing the molecular mechanisms 
underlying the toxicity of cyanobacteria. 
We could demonstrate that the notorious 
toxic cyanobacterium Microcystis produc-
es an additional class of toxins, the cyano-
peptolins, in addition to the well-known 
microcystins.[26] Cyanopeptolin 1020 was 
shown to constitute a ‘dirty’ protease in-
hibitor with IC
50
 values down to pM con-
centrations.[26] In addition, we have charac-
terized new microcystin variants both from 
freshwater strains in Uganda and Austria, 
and have investigated the structural basis 
for toxicity.[27]
Natural Products for Regenerative 
Medicine
We are interested in natural products 
that could be utilized in the broad field of 
regenerative medicine. In particular, we in-
vestigate compounds that can counter neu-
ritic atrophy by inducing neurite outgrowth 
or that can facilitate synapse reconstruc-
tion. These processes could also be of rel-
evance to cognitive enhancement by small 
molecule natural products (neurodoping). 
We have synthesized withanolide A (Fig. 
4),[28] which has been shown by Tohda et 
al. to facilitate neurite outgrowth and syn-
apse reconstruction,[29] and have evaluated 
its biological properties and mechanism of 
action by cellular and enzymatic studies. 
In fact, withanolide A was able to induce 
neuritogenesis in SY5Y cells, these ef-
fects, however, were conditional to the use 
of medium and surface coating of wells.[28]
Another class of compounds display-
ing neuritogenic properties are phenyl-
pyridone alkaloids,[30] some of which have 
originally been isolated by Hamburger 
and coworkers.[31] We have developed a 
unified synthetic approach to this class 
of compounds and have prepared several 
natural products and putative natural prod-
ucts that have not (yet) been identified.[32] 
Interestingly, it could be shown that a se-
ries of such pyridone alkaloids, with vary-
ing length of the side chain, are all able to 
induce neurite outgrowth in primed PC-12 
cells.[32a] This complements earlier studies 
by our group on the synthesis and structure 
activity relationship studies of farinosone 
C,[33] elaborating key structural param-
eters for activity. Currently, this portfolio 
of neuritogenic natural products is further 
evaluated with regard to its mode of action 
and evaluation in in vivo models. The po-
tential of these compounds for cognitive 
enhancement and against neurodegenera-
tive diseases will be evaluated.
Conclusion
In conclusion, natural products offer 
unique opportunities for studying bio-
logical phenomena on a molecular level. 
Exploiting the mechanism of action of 
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